Literature DB >> 16766770

Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases.

C R Chalmers, D J Wilson, J Ward, P J Robinson, G J Toogood, M A Hull.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16766770      PMCID： PMC1856328          DOI： 10.1136/gut.2005.090571

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.

Authors:  Malin Sund; Yuki Hamano; Hikaru Sugimoto; Akulapalli Sudhakar; Mary Soubasakos; Udaya Yerramalla; Laura E Benjamin; Jack Lawler; Mark Kieran; Amish Shah; Raghu Kalluri
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 2.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

3.  Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model.

Authors:  A Jackson; H Haroon; X P Zhu; K L Li; N A Thacker; G Jayson
Journal:  NMR Biomed       Date:  2002-04       Impact factor: 4.044

4.  Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance.

Authors:  Li Ma; Piero del Soldato; John L Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

5.  Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies.

Authors:  Bruno Morgan; Anne L Thomas; Joachim Drevs; Juergen Hennig; Martin Buchert; Asvina Jivan; Mark A Horsfield; Klaus Mross; Howard A Ball; Lucy Lee; William Mietlowski; Stefan Fuxuis; Clemens Unger; Ken O'Byrne; Andrew Henry; Graham R Cherryman; Dirk Laurent; Margaret Dugan; Dieter Marmé; William P Steward
Journal:  J Clin Oncol       Date:  2003-09-29       Impact factor: 44.544

6.  Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases.

Authors:  Hanneke W M van Laarhoven; Mark Rijpkema; Cornelis J A Punt; Theo J Ruers; Jan C M Hendriks; Jelle O Barentsz; Arend Heerschap
Journal:  J Magn Reson Imaging       Date:  2003-09       Impact factor: 4.813

7.  The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases.

Authors:  Stephen W Fenwick; Giles J Toogood; J Peter A Lodge; Mark A Hull
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

8.  Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.

Authors:  Milica Medved; Greg Karczmar; Cheng Yang; James Dignam; Thomas F Gajewski; Hedy Kindler; Everett Vokes; Peter MacEneany; Myrosia T Mitchell; Walter M Stadler
Journal:  J Magn Reson Imaging       Date:  2004-07       Impact factor: 4.813

Review 9.  Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.

Authors:  M O Leach; K M Brindle; J L Evelhoch; J R Griffiths; M R Horsman; A Jackson; G Jayson; I R Judson; M V Knopp; R J Maxwell; D McIntyre; A R Padhani; P Price; R Rathbone; G Rustin; P S Tofts; G M Tozer; W Vennart; J C Waterton; S R Williams; P Workman
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813
  10 in total
  3 in total

Review 1.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

2.  Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

Authors:  D Gomez; S Farid; H Z Malik; A L Young; G J Toogood; J P A Lodge; K R Prasad
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

3.  Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.

Authors:  Alastair L Young; Claire R Chalmers; Gillian Hawcroft; Sarah L Perry; Darren Treanor; Giles J Toogood; Pamela F Jones; Mark A Hull
Journal:  BMC Cancer       Date:  2013-02-26       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.